Balance Sheet
Accumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Scienjoy Holding (SJ) Receivables - Other (2019 - 2025)

Historic Receivables - Other for Scienjoy Holding (SJ) over the last 7 years, with Q3 2025 value amounting to $100.0 million.

  • Scienjoy Holding's Receivables - Other changed N/A to $100.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $100.0 million, marking a year-over-year change of. This contributed to the annual value of $317000.0 for FY2024, which is 8468.64% up from last year.
  • Per Scienjoy Holding's latest filing, its Receivables - Other stood at $100.0 million for Q3 2025.
  • Scienjoy Holding's 5-year Receivables - Other high stood at $13.0 billion for Q1 2021, and its period low was $9000.0 during Q2 2023.
  • In the last 5 years, Scienjoy Holding's Receivables - Other had a median value of $324000.0 in 2022 and averaged $2.7 billion.
  • Its Receivables - Other has fluctuated over the past 5 years, first surged by 18581418571.43% in 2021, then plummeted by 9999.88% in 2022.
  • Scienjoy Holding's Receivables - Other (Quarter) stood at $165637.8 in 2021, then rose by 26.23% to $209078.3 in 2022, then decreased by 19.42% to $168470.4 in 2023, then surged by 88.16% to $317000.0 in 2024, then skyrocketed by 31445.74% to $100.0 million in 2025.
  • Its Receivables - Other stands at $100.0 million for Q3 2025, versus $14000.0 for Q2 2025 and $100.0 million for Q1 2025.